82 related articles for article (PubMed ID: 1880687)
1. Drug depots in lymph nodes: which carrier is most appropriate?
Hirnle P
J Microencapsul; 1991; 8(1):103-19. PubMed ID: 1880687
[TBL] [Abstract][Full Text] [Related]
2. Liposomes for drug targeting in the lymphatic system.
Hirnle P
Hybridoma; 1997 Feb; 16(1):127-32. PubMed ID: 9085139
[TBL] [Abstract][Full Text] [Related]
3. Targeted introduction of substances into the lymph nodes for endolymphatic therapy.
Hirnle P
Cancer Treat Res; 2007; 135():101-18. PubMed ID: 17953411
[No Abstract] [Full Text] [Related]
4. [Targeting delivery of liposomal adriamycin by intra-lymphatic infusion].
Feng B; Lang J; Li D
Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):156-8. PubMed ID: 9596890
[TBL] [Abstract][Full Text] [Related]
5. [Endolymphatic therapy].
Slusarczyk K; Ziółko E; Bucior J
Pol Merkur Lekarski; 2001 Dec; 11(66):530-1. PubMed ID: 11899855
[TBL] [Abstract][Full Text] [Related]
6. [Participation of the lymphatic system in the metastasis of malignant tumors].
Kraev AV; Levin IuM; Nikitina RG
Vopr Onkol; 1977; 23(7):74-83. PubMed ID: 906400
[No Abstract] [Full Text] [Related]
7. Drug delivery to lymphatic tissue.
Papisov M; Weissleder R
Crit Rev Ther Drug Carrier Syst; 1996; 13(1-2):57-84. PubMed ID: 8853959
[TBL] [Abstract][Full Text] [Related]
8. Novel method of greatly enhanced delivery of liposomes to lymph nodes.
Phillips WT; Klipper R; Goins B
J Pharmacol Exp Ther; 2000 Oct; 295(1):309-13. PubMed ID: 10991995
[TBL] [Abstract][Full Text] [Related]
9. [Drug concentration in axillary lymph nodes of patients with breast cancer after lymphatic chemotherapy].
Chen JH; Yang YM; Li KZ; Ling R; Yao Q; Yang H
Ai Zheng; 2005 Apr; 24(4):494-7. PubMed ID: 15820077
[TBL] [Abstract][Full Text] [Related]
10. Distribution of doxorubicin in the bladder wall and regional lymph nodes after bladder submucosal injection of liposomal doxorubicin in the dog.
Kiyokawa H; Igawa Y; Muraishi O; Katsuyama Y; Iizuka K; Nishizawa O
J Urol; 1999 Feb; 161(2):665-7. PubMed ID: 9915479
[TBL] [Abstract][Full Text] [Related]
11. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats.
Kim CK; Han JH
J Microencapsul; 1995; 12(4):437-46. PubMed ID: 8583318
[TBL] [Abstract][Full Text] [Related]
12. [Indication establishment and dosimetry in endolymphatic therapy with I-131 lipiodol].
Winkel K; Becker J; Jahns E; Scheurlen H; Herzfeld U
Strahlentherapie; 1967 Aug; 133(4):481-98. PubMed ID: 4298455
[No Abstract] [Full Text] [Related]
13. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
Désormeaux A; Bergeron MG
Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
[TBL] [Abstract][Full Text] [Related]
14. [Metastasis to the lymph nodes as an index of the effectiveness of preoperative endolymphatic polychemotherapy of cervix cancer].
Pankov AK; Sidorenko IuS; Il'inskaia EG; Ogorodnikova LS; Zubkova TV
Vopr Onkol; 1978; 24(3):26-30. PubMed ID: 347711
[TBL] [Abstract][Full Text] [Related]
15. Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery.
Harrington KJ; Rowlinson-Busza G; Syrigos KN; Uster PS; Vile RG; Stewart JS
Clin Cancer Res; 2000 Jun; 6(6):2528-37. PubMed ID: 10873109
[TBL] [Abstract][Full Text] [Related]
16. Distribution and consequences of cell suspensions following intralymphatic infusion.
Juillard GJ; Boyer PJ; Niewisch H; Hom M
Bull Cancer; 1979; 66(3):217-28. PubMed ID: 486731
[TBL] [Abstract][Full Text] [Related]
17. [Experimental study of the endolymphatic use of gentamycin and klaforan (cefotaxime)].
Shcherbakova EG; Vyrenko IuE; Zhuravleva TP; Vazilo VE; Rastunova GA
Antibiotiki; 1982 May; 27(5):359-64. PubMed ID: 6285807
[TBL] [Abstract][Full Text] [Related]
18. Lymphatic absorption and tissue disposition of liposome-entrapped [14C]adriamycin following intraperitoneal administration to rats.
Parker RJ; Hartman KD; Sieber SM
Cancer Res; 1981 Apr; 41(4):1311-7. PubMed ID: 7214320
[TBL] [Abstract][Full Text] [Related]
19. Endolymphatic radionuclide therapy.
Kubícek J; Vizda J; Urbanová E; Morávek F
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1979; 22(2):101-14. PubMed ID: 293870
[No Abstract] [Full Text] [Related]
20. Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers.
Ryan GM; Kaminskas LM; Porter CJ
J Control Release; 2014 Nov; 193():241-56. PubMed ID: 24801249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
